Premium
O5‐05‐04: PLASMA NEUROFILAMENT LIGHT MEASUREMENTS IN MORE THAN 2,100 PRESENILIN‐1 E280A MUTATION CARRIERS AND NON‐CARRIERS FROM THE WORLD'S LARGEST AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDRED
Author(s) -
Quiroz Yakeel T.,
Zetterberg Henrik,
Reiman Eric M.,
Chen Yinghua,
Garcia Gloria,
Villegas L Andres,
Sepulveda Diego,
Villada Marina,
Arboleda-Velasquez Joseph F.,
Giraldo Margarita,
Guzman-Velez Edmarie,
Vila-Castelar Clara,
Pardilla-Delgado Enmanuelle,
Fuller Joshua,
Protas Hillary,
Ghisays Valentina,
Su Yi,
Gordon Brian A.,
Schultz Stephanie A.,
Romenets Silvia Rios,
Tariot Pierre N.,
Blennow Kaj,
Lopera Francisco
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.4861
Subject(s) - psen1 , medicine , oncology , presenilin , cardiology , endocrinology , gastroenterology , alzheimer's disease , disease
Frans R. J. Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Sarah Westwood, Lars Bertram, Cristina Legido-Quigley, Prof. Simon Lovestone, Johannes Streffer, Ulf Andreasson, Kaj Blennow, Frederik Barkhof, Henrik Zetterberg, Pieter Jelle Visser, Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, AmsterdamUMC, Amsterdam, Netherlands; Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium; UZ Brussel and Vrije Universiteit Brussel, Brussels, Belgium; Laboratory of Alzheimer’s Neuroimaging and Epidemiology LANE, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; University of Geneva, Geneva, Switzerland; Aix-Marseille University-CNRS, Marseille, France; GSK, Neurosciences Therapeutic Area, London, United Kingdom; University of Lille, Inserm, CHU Lille, Lille, France; Aristotle University of Thessaloniki, Thessaloniki, Greece; Geneva University Hospital, Geneva, Switzerland; University Hospital Lausanne, Lausanne, Switzerland; Fundaci on CITA-Alzh eimer Fundazioa, San Sebastian, Spain; KU Leuven, Leuven, Belgium; University Hospital of Leuven, Leuven, Belgium; University of Oxford, Oxford, United Kingdom; Imperial College London, London, United Kingdom; University of Oslo, Oslo, Norway; University of L€ubeck, L€ubeck, Germany; King’s College London, London, United Kingdom; Steno Diabetes Center Copenhagen, Copenhagen, Denmark; Janssen Pharmaceutica, Beerse, Belgium; UCB Biopharma SPRL, Brain-l’Alleud, Belgium; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, M€olndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M€olndal, Sweden; Translational Imaging Group, Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, UCL, London, United Kingdom; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands; UK Dementia Research Institute at UCL, London, United Kingdom; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Queen Square Institute of Neurology, Department of Neurodegenerative Disease, University College London, London, United Kingdom; Department of Neurobiology, Care Sciences Division of Neurogeriatrics, Karolinska Institutet, Huddinge, Sweden. Contact e-mail: s.vos@maastrichtuniversity.nl